Increased efficacy of HIV-1 neutralization by antibodies at low CCR5 surface concentration
- 4 August 2006
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 348 (3), 1107-1115
- https://doi.org/10.1016/j.bbrc.2006.07.163
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Neutralization and infectivity characteristics of envelope glycoproteins from human immunodeficiency virus type 1 infected donors whose sera exhibit broadly cross-reactive neutralizing activityVirology, 2005
- Structure of a V3-Containing HIV-1 gp120 CoreScience, 2005
- Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal AntibodiesJournal of Virology, 2004
- How Viruses Enter Animal CellsScience, 2004
- Virus entry: molecular mechanisms and biomedical applicationsNature Reviews Microbiology, 2004
- Crystal Structure of the Broadly Cross-Reactive HIV-1-Neutralizing Fab X5 and Fine Mapping of Its Epitope,Biochemistry, 2004
- Access of Antibody Molecules to the Conserved Coreceptor Binding Site on Glycoprotein gp120 Is Sterically Restricted on Primary Human Immunodeficiency Virus Type 1Journal of Virology, 2003
- Human Immunodeficiency Virus Type 1 Infection Is Associated with Significant Mucosal Inflammation Characterized by Increased Expression of CCR5, CXCR4, and β‐ChemokinesThe Journal of Infectious Diseases, 2000
- Lamina Propria Lymphocytes, Not Macrophages, Express CCR5 and CXCR4 and Are the Likely Target Cell for Human Immunodeficiency Virus Type 1 in the Intestinal MucosaThe Journal of Infectious Diseases, 2000
- Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissueAIDS, 2000